PlainPharmaWatch

CMS Open Payments · Tool

InspireMD Ltd vs US Endoscopy

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

US Endoscopy has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,854, versus 302 for the other company. Its single largest recorded recipient represents 40.8% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

InspireMD Ltd
HHI 302 · top recipient 6.1%
Ranked #1,458 of 1,838 companies by HHI
US Endoscopy
HHI 2,854 · top recipient 40.8%
Ranked #588 of 1,838 companies by HHI

Payment Overview

Company A

InspireMD Ltd

Total Payments
$983.4K
% of Industry
0.0%
Transactions
97
Avg per Transaction
$10.1K
Recipients
64
Avg per Recipient
$15.4K
Payment Types
1
Top Payment Type
Food and Beverage
Company B

US Endoscopy

Total Payments
$971.8K
% of Industry
0.0%
Transactions
103
Avg per Transaction
$9.4K
Recipients
103
Avg per Recipient
$9.4K
Payment Types
2
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

InspireMD Ltd vs US Endoscopy - total reported payments in CMS Open Payments PY2024

InspireMD Ltd$983.4KUS Endoscopy$971.8K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

InspireMD Ltd

Food and Beverage $11.0K

100.0%

US Endoscopy

Royalty or License $798.2K

82.1%

Consulting Fee $173.6K

17.9%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

InspireMD Ltd

  1. 1

    SEAN LYDEN

    $671.00 · 1 txns

  2. 2

    Erin Murphy

    $623.00 · 1 txns

  3. 3

    ANISH THOMAS

    $515.00 · 1 txns

  4. 4

    ERIC SECEMSKY

    $473.00 · 1 txns

  5. 5

    JOHN BACHARACH

    $456.00 · 1 txns

US Endoscopy

  1. 1

    BENNETT ROTH

    $396,092.15 · 4 txns

  2. 2

    DAVID CARR LOCKE

    $325,165.55 · 4 txns

  3. 3

    DAVID FLEISCHER

    $72,994.52 · 5 txns

  4. 4

    SONALI SETHI

    $19,659.00 · 7 txns

  5. 5

    NEIL SHARMA

    $14,750.00 · 4 txns

Summary Comparison

Metric InspireMD Ltd US Endoscopy
Total Payments $983.4K $971.8K
% of Industry Total 0.0% 0.0%
Transaction Count 97 103
Avg per Transaction $10.1K $9.4K
Recipient Count 64 103
Avg per Recipient $15.4K $9.4K
Payment Type Count 1 2
Top Payment Type Food and Beverage Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.